{"@id":"https://bioecon.ru/technology/macrophage-drug-conjugates/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/macrophage-drug-conjugates/","json":"https://cn.bioecon.ru/api/v1/technology/macrophage-drug-conjugates/index.json"},"id":"macrophage-drug-conjugates","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/china-resources-pharmaceutical/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/biogenic-aps/","https://bioecon.ru/companies/bioaqua/"]},"maturity":6,"name":"靶向实体瘤的巨噬细胞药物偶联物","regions":["ch","eu","us","cn"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"单核细胞定向体外分化"},{"n":2,"title":"生物相容性纳米载荷温和偶联"},{"n":3,"title":"趋化因子梯度主动跨膜穿透"},{"n":4,"title":"缺氧坏死核心靶向释药"}],"summary":"以同种异体或自体原代巨噬细胞为活体药物载体，负载细胞毒性或免疫调节载荷，主动靶向趋化并穿透胰腺癌、脑胶质瘤等致密低氧实体瘤核心。","url":"/technology/macrophage-drug-conjugates/","verified":"2026-11-22"}